DỮ LIỆU BÁO CÁO THƯỜNG NIÊN
CÁC CÔNG TY NIÊM YẾT NƯỚC NGOÀI

Lượt xem: 1
Danh sách Báo cáo các công ty nước ngoài
Tìm kiếm Báo cáo các công ty nước ngoài

Báo cáo thường niên năm 2022 của Biomea Fusion

Biomea Fusion, they develop medicines to improve the life of the individual. The name biomea derives from the Greek word bios, meaning “life,” and the Latin word mea, meaning “my.” They are a biopharmaceutical company focused on the discovery and development of covalent small molecules to treat patients with genetically defined cancers and metabolic diseases. A covalent small molecule is … More a synthetic compound that forms a permanent bond to its target protein and offers a number of potential advantages over conventional non-covalent drugs including greater target selectivity, lower drug exposure and the ability to drive a deeper, more durable response. Leveraging their extensive expertise in covalent binding chemistry and development, they built their proprietary FUSION™ System platform to advance a pipeline of novel covalent therapies. Their lead product candidate, BMF-219, is an orally bioavailable, potent and selective covalent inhibitor of MENIN, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers. Beyond BMF-219, they are utilizing their novel platform to develop covalent treatments against other high-value oncogenic drivers of cancer. Their goal is to utilize their capabilities and platform to become a leader in developing covalent small molecules in order to maximize the depth and durability of clinical benefit when treating various cancers.

TÊN CÔNG TY / COMPANY
Biomea Fusion

SÀN CHỨNG KHOÁN / STOCK EXCHANGE
NASDAQ (US)

MÃ CHỨNG KHOÁN / TICKER
BMEA

KỲ BÁO CÁO
2022

NGÀNH / INDUSTRY
Biotechnology

LĨNH VỰC / SECTOR
Healthcare

LƯU Ý

  • Xin vui lòng đợi một lát để Báo cáo được tải về, tùy thuộc vào dung lượng của Báo cáo mà thời gian có thể nhanh hoặc chậm.
  • Báo cáo chỉ cho phép xem từ Việt Nam.
NASDAQ_BMEA_2022-DATA.KRESTON.VN

Có thể bạn quan tâm: